GL1X · GenesisL1 explorer

MolNFT v1 · #113125 · protein

Approved drugs containing thiols as inhibitors of metallo-beta- lactamases: strategy to combat multidrug-resistant bacteria

5A5Z · Beta-lactamase ndm-1: “Approved drugs containing thiols as inhibitors of metallo-beta- lactamases: strategy to combat…”. X-ray diffraction, 2 ligands (WJZ, ZN), 3 pockets (best druggability 0.78). MolNFT v1 #113125 on GenesisL1: 3D…

PDB
5A5Z
Type
protein
Length
472 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Beta-lactamase ndm-1
EC
3.5.2.6
UniProt
C7C422
Ligands
WJZ, ZN
Pockets
3 · best druggability 0.78

Structure

x-ray diffraction · 1 distinct chain · 23% helix, 31% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, CBeta-lactamase ndm-1 (EC 3.5.2.6)protein23623% helix, 31% strandC7C422

Ligands and binding sites

  • WJZ · Tiopronin · ligand · 2 copies · chains A, C
  • ZN · Zinc ion · metal · 4 copies · chains A, C

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11010.780.9820empty
21470.430.7525ZN, WJZ
31060.370.7420ZN, WJZ

Interfaces

1 interface between chains.

  • A–C · 906 Ų buried · 6 hydrogen bonds · protein-protein

Compared structures

  • 5A5Z · Approved Drugs Containing Thiols as Inhibitors of Metallo-beta- lactamases: Strategy To… · the same entry in another collection · chain A against A, TM-score 1.00
  • C7C422 · AlphaFold monomer V2.0 prediction for metallo-beta-lactamase type 2 (C7C422) · a predicted model of the same protein · chain A against A, TM-score 0.97

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.